Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight https://www.globenewswire.com/news-release/2023/05/10/2665215/0/en/Boehringer-Ingelheim-and-Zealand-Pharma-announce-phase-II-trial-showed-14-9-weight-loss-in-people-living-with-obesity-or-overweight.html press release